Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
NCT01391156 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2012-07-20
Summary
The purpose of this study is to compare the efficacy of 3% Minoxidil lotion and 3% Minoxidil with 0.1% Finasteride lotion for 6 months in male pattern hair loss.
Conditions
Interventions
- DRUG
-
3%Minoxidil lotion
3% Minoxidil lotion apply two times a day
- DRUG
-
3% Minoxidil with 0.1% Finasteride lotion
3% Minoxidil with 0.1% Finasteride lotion apply two times a day.
Sponsors & Collaborators
-
Mae Fah Luang University Hospital
lead OTHER
Principal Investigators
-
Chuchai Tanglertsampan, MD · Mae Fah Luang University Hospital(Bangkok)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2012-03-31
- Completion
- 2012-03-31
Countries
- Thailand
Study Locations
More Related Trials
-
Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia
NCT01319370 ·Status: COMPLETED ·Phase: PHASE2
-
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
NCT02460289 ·Status: COMPLETED ·Phase: NA
-
Minoxidil Response Testing in Males With Androgenetic Alopecia
NCT02198261 ·Status: COMPLETED
-
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
NCT07011485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss
NCT06590779 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia
NCT06043349 ·Status: UNKNOWN ·Phase: PHASE4
-
Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata
NCT05587257 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men
NCT05989165 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia
NCT05990400 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
NCT07080931 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment of Androgenetic Alopecia in Men for 24 Weeks
NCT04721548 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement
NCT02275832 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
NCT02154503 ·Status: UNKNOWN ·Phase: PHASE1
-
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
NCT02486848 ·Status: WITHDRAWN ·Phase: NA
-
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement
NCT02283645 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients
NCT01655108 ·Status: UNKNOWN ·Phase: PHASE3
-
Minoxidil 2% for Eyebrow Enhancement
NCT01672307 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
NCT04594018 ·Status: RECRUITING ·Phase: PHASE3
-
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
NCT03535233 ·Status: COMPLETED ·Phase: PHASE4
-
Minoxidil for Treating White Hair: A Randomized Controlled Trial
NCT06813963 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
NCT02483195 ·Status: WITHDRAWN ·Phase: PHASE4
-
Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia
NCT05369481 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial in Females for Female Pattern Hair Loss
NCT01226459 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
NCT01325337 ·Status: COMPLETED ·Phase: PHASE2